Phase 1 Safety and Pharmacokinetics Study of MK-2048/Vicriviroc (MK-4176)/MK-2048A Intravaginal Rings

BACKGROUND: Vaginal rings (VR) containing antiretroviral (ARV) drugs can be utilized for prevention of human immunodeficiency virus (HIV) with potential for improved adherence compared to daily pills. Combination ARV VRs could improve efficacy. METHODS: MTN-027, a single-blind, randomized, placebo-c...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Clin Infect Dis
Main Authors: Hoesley, Craig J, Chen, Beatrice A, Anderson, Peter L, Dezzutti, Charlene S, Strizki, Julie, Sprinkle, Carol, Heard, Faye, Bauermeister, Jose, Hall, Wayne, Jacobson, Cindy, Berthiaume, Jennifer, Mayo, Ashley, Gundacker, Holly, Richardson-Harman, Nicola, Piper, Jeanna
Formato: Artigo
Idioma:Inglês
Publicado em: Oxford University Press 2019
Assuntos:
Articles and Commentaries
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6424075/
https://ncbi.nlm.nih.gov/pubmed/30289435
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/cid/ciy653
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados